Valuation: Fresenius SE & Co. KGaA

Capitalization 27.06B 31.51B 25.31B 23.64B 43.62B 2,833B 47.46B 293B 114B 1,343B 118B 116B 4,928B P/E ratio 2025 *
17.6x
P/E ratio 2026 * 14.1x
Enterprise value 38.48B 44.82B 35.99B 33.62B 62.04B 4,029B 67.5B 417B 163B 1,910B 168B 165B 7,008B EV / Sales 2025 *
1.71x
EV / Sales 2026 * 1.59x
Free-Float
73.04%
Yield 2025 *
2.28%
Yield 2026 * 2.45%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.01%
1 week+1.35%
Current month+1.48%
1 month+0.25%
3 months+1.63%
6 months+9.21%
Current year+43.20%
More quotes
1 week 46.79
Extreme 46.79
48.48
1 month 46.06
Extreme 46.06
50.1
Current year 31.6
Extreme 31.6
50.74
1 year 31.6
Extreme 31.6
50.74
3 years 23.29
Extreme 23.29
50.74
5 years 19.69
Extreme 19.69
50.74
10 years 19.69
Extreme 19.69
80.07
More quotes
Manager TitleAgeSince
Chief Executive Officer 57 30/09/2022
Director of Finance/CFO 45 31/08/2022
Compliance Officer 49 -
Director TitleAgeSince
Director/Board Member 71 19/05/2015
Director/Board Member 65 12/05/2016
Director/Board Member 51 31/12/2007
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+2.85%+1.35%+41.72%+80.09% 31.51B
-4.05%-3.71%+47.96%+97.29% 107B
+0.93%+5.29%+43.19%-22.31% 100B
+0.54%+5.29%-14.02%+18.17% 24.14B
+1.52%-1.42%+11.70%+12.17% 21.72B
-0.06%-1.70%+13.28%+20.60% 19.97B
-0.14%-3.69%+59.57%+67.06% 17.76B
-2.24%-6.56%+41.96%+351.36% 17.35B
-1.11%-3.17%+16.25%+75.02% 13.92B
+2.26%-1.12%-12.27%+31.48% 13.26B
Average -0.48%-0.98%+24.94%+73.09% 36.68B
Weighted average by Cap. -0.97%-0.00%+34.91%+56.04%
See all sector performances

Financials

2025 *2026 *
Net sales 22.55B 26.26B 21.09B 19.7B 36.35B 2,361B 39.55B 245B 95.29B 1,119B 98.56B 96.47B 4,107B 23.74B 27.65B 22.2B 20.74B 38.27B 2,485B 41.64B 257B 100B 1,178B 104B 102B 4,323B
Net income 1.55B 1.8B 1.45B 1.35B 2.5B 162B 2.72B 16.79B 6.54B 76.82B 6.77B 6.62B 282B 1.94B 2.26B 1.81B 1.7B 3.13B 203B 3.4B 21.04B 8.2B 96.29B 8.48B 8.3B 353B
Net Debt 11.43B 13.31B 10.69B 9.98B 18.42B 1,196B 20.04B 124B 48.28B 567B 49.94B 48.88B 2,081B 10.61B 12.36B 9.92B 9.27B 17.11B 1,111B 18.61B 115B 44.84B 527B 46.38B 45.4B 1,932B
More financial data * Estimated data
Logo Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (59.2%; Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (39.1%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. ; - other (1.7%).
Employees
177,356
More about the company
Date Price Change Volume
10/12/25 48.04 +2.30% 786,413
09/12/25 46.96 -1.45% 424,309
08/12/25 47.65 +0.21% 507,785
05/12/25 47.55 -0.65% 478,199
04/12/25 47.86 +0.99% 678,710

Delayed Quote Xetra, December 10, 2025 at 05:11 pm

More quotes
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
48.04EUR
Average target price
54.26EUR
Spread / Average Target
+12.94%
Consensus

Quarterly revenue - Rate of surprise